2019
DOI: 10.1136/bcr-2018-227860
|View full text |Cite
|
Sign up to set email alerts
|

Haemophagocytic lymphohistiocytosis with collapsing lupus podocytopathy as an unusual manifestation of systemic lupus erythematosus with APOL1 double-risk alleles

Abstract: Haemophagocytic lymphohistiocytosis (HLH) is a potentially life-threatening syndrome caused by excessive immune activation. Secondary HLH has been described in autoimmune diseases. We detail the case of a 28-year-old African American woman who developed HLH in the setting of systemic lupus erythematosus with collapsing lupus podocytopathy superimposed on mesangial proliferative lupus nephritis class II. Genotyping for APOL1 risk alleles revealed the presence of double (G1/G2) risk alleles. Our patient achieved… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 19 publications
0
7
0
Order By: Relevance
“…MMF reversibly inhibits inosine monophosphate dehydrogenase, leading to decreased B cell and T cell proliferation and decreased cytokine production, which might consequently suppress the dysfunction in secondary HLH 45 . In addition, 2 SLE patients with secondary HLH were reported to be successfully treated with MMF, indicating the potential of MMF to cure secondary HLH in patients with CTD 46,47 . e significance, however, vanished aer adjusting for factors including infection and disease activity.…”
Section: Discussionmentioning
confidence: 99%
“…MMF reversibly inhibits inosine monophosphate dehydrogenase, leading to decreased B cell and T cell proliferation and decreased cytokine production, which might consequently suppress the dysfunction in secondary HLH 45 . In addition, 2 SLE patients with secondary HLH were reported to be successfully treated with MMF, indicating the potential of MMF to cure secondary HLH in patients with CTD 46,47 . e significance, however, vanished aer adjusting for factors including infection and disease activity.…”
Section: Discussionmentioning
confidence: 99%
“…Provocative, indirect evidence raises the possibility of a complex relationship between JC viruses, APOL1 genotype, and kidney disease, although the precise nature of this interaction is not yet fully understood (67). Acute glomerulopathy has also been observed with hemophagocytic lymphohistiocytosis, a disease driven by aberrant cytokine production (68). Recently, cases of collapsing glomerulopathy have been reported in the setting of acute SARS-CoV-2 coronavirus infection, a transient high-cytokine state (69,70).…”
Section: Triggers Of Apol1 Kidney Disease: Beyond Susceptibilitymentioning
confidence: 99%
“… 12 , 13 The higher incidence in individuals of African descent suggests underlying genetic factors, such as the presence of nephropathic apolipoprotein L1 variants, as recently documented in a patient with HLH and collapsing lupus podocytopathy. 19 Close to two-thirds of reported patients with HLH-associated nephrotic syndrome died of HLH-associated multiorgan failure. 18 The outcomes of the few surviving patients were variable; some had remission of nephrotic syndrome, while others developed chronic kidney disease.…”
Section: Discussionmentioning
confidence: 99%